Effects of mobile phone application combined with or without self‐monitoring of blood glucose on glycemic control in patients with diabetes: A randomized controlled trial. Issue 5 (19th March 2019)

• Record Type: Journal Article
• Authors: Yu, Yuan; Yan, Qun; Li, Huizhi; Li, Hongmei; Wang, Lin; Wang, Hua; Zhang, Yiyun; Xu, Lei; Tang, Zhaosheng; Yan, Xinfeng; Chen, Yinghua; He, Huili; Chen, Jie; Feng, Bo
• Is Part Of: Journal of diabetes investigation. Volume 10:Issue 5(2019)
• Page Start: 1365
• Page End: 1371
• Publication Date: 2019-03-19
• Subjects: Diabetes mellitus -- Mobile applications -- Self‐monitoring of blood glucose; Diabetes -- Periodicals; Diabetes -- Research -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462005
• DOI: 10.1111/jdi.13031
• Languages: English
• ISSNs: 2040-1116

Abstract

Abstract: Aims/Introduction: There is potential for mobile applications to deliver new self‐management interventions for chronic disease, especially in diabetes. The aim of the present study was to evaluate the effects of a mobile phone application (MPA) combined with or without self‐monitoring of blood glucose (SMBG) on glycemic control in patients with diabetes. Materials and Methods: The study was a 24‐week period, four‐arm parallel group, non‐blinded, randomized trial. A total of 185 patients with mean age of 52 years were randomized to group A (no MPA and no SMBG), group B (SMBG only), group C (MPA only) and group D (both MPA and SMBG were used). Changes in glycated hemoglobin (HbA1c), fasting plasma glucose and 1, 5‐anhydroglucitol from baseline to week 24 were analyzed. Results: At 24 weeks, the HbA1c levels in patients of all groups decreased significantly from baseline. There were significant differences in the proportions of patients that achieved HbA1c <7% between groups, especially in group C and group D, compared with group A at week 24 (60.4%, 62.2% vs 25.5%, all P < 0.05). 1, 5‐Anhydroglucitol changes were obvious in group A and group C at week 24 from baseline (all P < 0.05 within groups). Factorial analysis of anova showed that MPA intervention was the main effective factor for HbA1c change ( F = 4.59, P = 0.034), and there was no effect on HbA1c change for SMBG intervention ( P = 0.975). Conclusions: Implementation of the MPA, Diabetes‐Carer, is effective in improving the proportion of HbA1c <7% in patients with type 2 diabetes. Abstract : Mobile applications have the potential to deliver new self‐management interventions for diabetes. In this randomized controlled trial, we confirmed that the implementation of the mobile phone application, Diabetes‐Carer, is effective in improving the proportion of glycated hemoglobin (<7%) in type 2 diabetes patients.